uniQure N.V.
NASDAQ:QURE
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases.
Featured Articles and Interviews
Jan 16, 2025
Top 5 NASDAQ Genetics Stocks (Updated January 2025)
More Featured Articles and Inverviews
Press Releases
More Press Releases
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Interactive Chart
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â